HLA Class I Antibody (MEM-81) [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # NB500-412B
![Novus Antibodies Novus Antibodies](https://resources.rndsystems.com/categoryimages/novus_antibodies.jpg)
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
Biotin
Antibody Source
Monoclonal Mouse IgG1 Clone # MEM-81
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Leukocytes of a patient suffering with LGL type leukemia.
Specificity
The antibody MEM-81 reacts with human classical MHC Class I molecules in native cell-surface forms. MHC Class I molecules (MHC Class Ia) are expressed on the surface of human nucleated cell types.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for HLA Class I Antibody (MEM-81) [Biotin]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: HLA Class I
Long Name
Class I Human Leukocyte Antigen
Alternate Names
HLA-A, HLA-ABC
Gene Symbol
HLA-A
Additional HLA Class I Products
Product Documents for HLA Class I Antibody (MEM-81) [Biotin]
Product Specific Notices for HLA Class I Antibody (MEM-81) [Biotin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...